Skip to content

K-SAB trial

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515250-25-00
Acronym
K-SAB
Enrollment
20
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced KRASG12C-mutated non-small cell lung cancer subjects who previosly progressed on at least one prior line of therapy, or who have contraindications for immuno/chemotherapy.

Interventions

None listed

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026